Brief: Iterum Therapeutics Granted 180-Day Extension By Nasdaq To Regain Compliance With Bid Price Rule
10/03/2022 14:07
March 10 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS GRANTED 180-DAY EXTENSION BY NASDAQ TO
REGAIN COMPLIANCE WITH BID PRICE RULE
Source text for Eikon: ID:nGNX47gHl3
Further company coverage: ITRM.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity